Demo corpus. Scores are computed on a select set of biomedical paper/datasets and may be inaccurate for papers outside this corpus — DataRank relies on network effects that improve with scale. We aim to expand this into a fully open resource pending additional funding.
Epigenetic mechanisms as a new approach in cancer treatment: An updated review
N/A
5.5
208 citations · base score 5.3
›Data sources & pipeline
Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring
Enrichment:Pending
FAIR Checklist
Context only (not used in score)Findable (2/2)
- Has DOI
- Indexed in repositories
Accessible (0/2)
Interoperable (2/2)
- DataCite relations
- Linked datasets
Reusable (0/3)
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
DataRank Breakdown
Base Score 15%Citation Network 85%
Base Score Contribution
0.801
From this paper's citation signal
Citation Network Contribution
4.7
From 167 citing papers with measurable signal
Top citers
Why this DataRank?
DataRank blends this paper's own citation count with the influence of the papers that cite it. Here, roughly 15% comes from its base citations and 85% from the citation network (167 citing papers contributed measurable signal).
- Base score B(p)
- log1p(citation_count) — grows sub-linearly, so a paper with 1,000 citations is not 10× a paper with 100.
- Network N(p)
- Σ over citers of log1p(Cq) ÷ max(outdegreeq, 1). Being cited by a highly-cited paper with few references counts most.
- Damping factor d = 0.85
- DataRank = (1−d)·B(p) + d·N(p) — the two cards above are each already multiplied by their share.
- Self-citations excluded
- Citers sharing any OpenAlex author ID with this paper are filtered out before the network sum.
Citers are pulled from OpenAlex sorted by cited_by_count:descand capped per paper, so when the cap binds we keep the highest-signal references and the score is reproducible across reruns.